跳至主要内容
临床试验/EUCTR2015-005338-23-NL
EUCTR2015-005338-23-NL进行中(未招募)1 期

Targeting fear memory by disrupting the process of memory reconsolidation: A new intervention for panic disorder.

niversity of Amsterdam0 个研究点开始时间: 2016年7月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Aged between 18 and 65 years
  • - A primary diagnosis of panic disorder according to DSM-V
  • - Written approval of an independent physician for participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Other relevant treatment for panic disorder at the time of study - e.g., CBT
  • - Diagnosis of depression
  • - Diagnosis of psychosis
  • - Use of psychotropic medication
  • - History of pulmonary diseases
  • - Metabolic acidosis
  • - History of cardiovascular diseases
  • - Heart problems among first-degree relatives
  • - BP < 90-60 or BP > 170-100
  • - History of black-outs or fainting
  • - Diabetes
  • - Liver or kidney diseases
  • - Hyperactive production of thyroid hormones
  • - Epilepsy
  • - Any medication contra-indicative of the use of propranolol
  • - Pregnancy

研究者

发起方
niversity of Amsterdam

相似试验

A new treatment for panic disorder | 临床试验